Cargando…

Dupilumab for the treatment of atopic dermatitis in transplant patients: Two case reports and literature review

Detalles Bibliográficos
Autores principales:	Napolitano, Maddalena, Nocerino, Mariateresa, Picone, Vincenzo, Martora, Fabrizio, Fabbrocini, Gabriella, Dastoli, Stefano, Patruno, Cataldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285570/ https://www.ncbi.nlm.nih.gov/pubmed/35048522 http://dx.doi.org/10.1111/dth.15324

Ejemplares similares

Effect of Dupilumab on Sexual Desire in Adult Patients with Moderate to Severe Atopic Dermatitis
por: Napolitano, Maddalena, et al.
Publicado: (2022)

Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report
por: Cantelli, Mariateresa, et al.
Publicado: (2022)

The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication
por: Napolitano, Maddalena, et al.
Publicado: (2022)

Vitiligo during dupilumab therapy
por: Picone, Vincenzo, et al.
Publicado: (2023)

COVID-19, quarantine, and atopic dermatitis
por: Patruno, Cataldo, et al.
Publicado: (2020)

Treatment of Atopic Dermatitis with Biologic Drugs
por: Fabbrocini, Gabriella, et al.
Publicado: (2018)

Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Urticaria relapse after mRNA COVID‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐center experience
por: Picone, Vincenzo, et al.
Publicado: (2022)

The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis
por: Napolitano, Maddalena, et al.
Publicado: (2023)

Profile of Baricitinib and Its Potential in the Treatment of Moderate to Severe Atopic Dermatitis: A Short Review on the Emerging Clinical Evidence
por: Napolitano, Maddalena, et al.
Publicado: (2020)

Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
por: Megna, Matteo, et al.
Publicado: (2022)

Efficacy and Safety of Dupilumab in Clinical Practice: One Year of Experience on 165 Adult Patients from a Tertiary Referral Centre
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Dupilumab for atopic dermatitis
Publicado: (2019)

Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study
por: Napolitano, Maddalena, et al.
Publicado: (2022)

A Case of New-Onset Lichen Planus after COVID-19 Vaccination
por: Picone, Vincenzo, et al.
Publicado: (2022)

Contact allergy in children with and without atopic dermatitis: An Italian multicentre study
por: Bonamonte, Domenico, et al.
Publicado: (2022)

A case of herpes zoster ophthalmicus after third dose of Comirnaty (BNT162b2 mRNA) vaccine
por: Martora, Fabrizio, et al.
Publicado: (2022)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

Systemic Treatment of Adult Atopic Dermatitis: A Review
por: Megna, Matteo, et al.
Publicado: (2016)

Reply: Potential role of Janus kinase inhibitors in COVID-19
por: Napolitano, Maddalena, et al.
Publicado: (2020)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

“Covid arm”: Abnormal side effect after Moderna COVID‐19 vaccine
por: Picone, Vincenzo, et al.
Publicado: (2021)

Hidradenitis suppurativa flares following COVID-19 vaccination: A case series
por: Martora, Fabrizio, et al.
Publicado: (2022)

Impact of COVID‐19 pandemic and the use of telemedicine on the diagnosis and treatment of tinea corporis: An experience of Southern Italy center
por: Picone, Vincenzo, et al.
Publicado: (2022)

“PiMa sign”: A possible correlation between dermographism and pityriasis versicolor?
por: Martora, Fabrizio, et al.
Publicado: (2022)

A case of linear psoriasis in a young patient with Down syndrome and review of the literature
por: Martora, Fabrizio, et al.
Publicado: (2022)

Prevalence of Chronic Inducible Urticaria in Elderly Patients
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Skin rashes after SARS‐CoV‐2 vaccine: which relationship, if any?
por: Patruno, Cataldo, et al.
Publicado: (2021)

Alopecia areata after dupilumab for atopic dermatitis
por: Mitchell, Krystal, et al.
Publicado: (2018)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
por: Ferreira, Sandra, et al.
Publicado: (2020)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
por: Zubek, Amanda E., et al.
Publicado: (2020)

Practical Management of Patients with Atopic Dermatitis on Dupilumab
por: Papp, Kim A., et al.
Publicado: (2021)

Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
por: de Bruin-Weller, Marjolein, et al.
Publicado: (2021)

The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2021)

Improvement of atopic dermatitis and alopecia universalis with dupilumab
por: Alotaibi, Lama, et al.
Publicado: (2021)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
por: Shan, Jinpeng, et al.
Publicado: (2022)

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Efficacy and safety of dupilumab in two adolescents with severe atopic dermatitis
por: Giavina-Bianchi, Mara, et al.
Publicado: (2021)

Dupilumab: Direct Cost and Clinical Evaluation in Patients with Atopic Dermatitis
por: Ferrari, Marco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rgm8bi785ckc546vibif7cmsnh